Literature DB >> 1591358

Progression of chronic renal failure on substituting a ketoacid supplement for an amino acid supplement.

M Walser1, S Hill, L Ward.   

Abstract

Twelve patients with severe chronic renal failure (average initial GFR, 13 mL/min) were monitored for 4 to 23 months while receiving an essential amino acid supplement and were then switched to a ketoacid supplement for 6 to 40 months, while continuously receiving a very low-protein (0.3 g/kg), low-phosphorus (7 to 9 mg/kg) diet. Urinary urea N excretion indicated that actual dietary protein intake averaged 0.46 g/kg. Progression, estimated as the linear regression slope of radioisotopically determined GFR on time, slowed from -0.46 +/- 0.31 (SD) to -0.24 +/- 0.15 mL/min/month (P = 0.029). Serum urea N, creatinine, phosphate, and uric acid rose significantly as GFR fell; blood pressure, plasma lipids, and urinary urea excretion were unchanged. Urinary 17-hydroxy-corticosteroid excretion decreased 18%, but this change was only marginally significant (P = 0.087). There was no change in plasma or urinary cortisol or urinary aldosterone. Viewed in light of previous evidence that progression seldom slows when treatment remains constant, the results suggest that this ketoacid supplement slows progression by approximately half, compared with an essential amino acid supplement, with no change in diet.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591358     DOI: 10.1681/ASN.V271178

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  4 in total

Review 1.  Diets and enteral supplements for improving outcomes in chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Noël J Cano; Klemens Budde; Charles Chazot; Csaba P Kovesdy; Robert H Mak; Rajnish Mehrotra; Dominic S Raj; Ashwini R Sehgal; Peter Stenvinkel; T Alp Ikizler
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

2.  The role of keto acids in the supportive treatment of children with chronic renal failure.

Authors:  Sevgi Mir; Nese Ozkayin; Aysegul Akgun
Journal:  Pediatr Nephrol       Date:  2005-04-26       Impact factor: 3.714

3.  Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease.

Authors:  Che-Hsiung Wu; Ya-Wen Yang; Szu-Chun Hung; Ko-Lin Kuo; Kwan-Dun Wu; Vin-Cent Wu; Tsung-Cheng Hsieh
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

4.  Very low protein diet plus ketoacid analogs of essential amino acids supplement to retard chronic kidney disease progression.

Authors:  Bancha Satirapoj; Peerapong Vongwattana; Ouppatham Supasyndh
Journal:  Kidney Res Clin Pract       Date:  2018-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.